Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity
Introduction: Adverse Events Following Immunization (AEFI) of the COVID-19 vaccine is one of the important considerations, especially in patients with autoimmunity. This study aims to compare the number of CoronaVac AEFIs in women with and without autoimmunity. Methodology: This is a retrospective c...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | Clinical Epidemiology and Global Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213398423000362 |
| _version_ | 1797849700003479552 |
|---|---|
| author | Stevent Sumantri Maria Aurelia Haryanto Euphemia Seto Anggraini Widyastuti |
| author_facet | Stevent Sumantri Maria Aurelia Haryanto Euphemia Seto Anggraini Widyastuti |
| author_sort | Stevent Sumantri |
| collection | DOAJ |
| description | Introduction: Adverse Events Following Immunization (AEFI) of the COVID-19 vaccine is one of the important considerations, especially in patients with autoimmunity. This study aims to compare the number of CoronaVac AEFIs in women with and without autoimmunity. Methodology: This is a retrospective cohort study with an unpaired comparative analytic design with a retrospective cohort method. We recruited 602 volunteers, 182 women with autoimmunity and 420 without autoimmunity. We included women who received the CoronaVac vaccine, aged 17–65 years. Data were analyzed using the chi-square or fisher exact method as an alternative. Results: We found a generally increased risk for AEFI in women with autoimmunity (RR = 1.179; 95% CI 1.059–1.313; p = 0.007) compared to women without autoimmunity, especially for systemic (RR = 1.1271; 95% CI 1.045–1.545; p = 0.025), allergic (RR = 2.052; 95% CI 1.070–3.932; p = 0.045), fever (RR = 2.163 95%; CI 1.093–4.282; p = 0.039), fatigue (RR = 2.182 95%; CI 1.558–3.056; p = 0.001), and headache (RR = 1.619 95%; CI 1.164–2.251; p = 0.006). On the other hand, we found no increased risk for the overall severity of AEFI (RR = 0.851 95% CI; 0.655–1.105; p = 0.256). We also found a relapse of autoimmune condition in 10.4% (n = 19) after CoronaVac vaccination. Conclusions: There is an increased risk of AEFI after CoronaVac vaccination in women with autoimmunity compared to those without the condition. Although the severity of AEFIs and risk of autoimmune relapse were relatively low. |
| first_indexed | 2024-04-09T18:49:28Z |
| format | Article |
| id | doaj.art-5f64085f029c4c7081c1ab452a6238cc |
| institution | Directory Open Access Journal |
| issn | 2213-3984 |
| language | English |
| last_indexed | 2024-04-09T18:49:28Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Clinical Epidemiology and Global Health |
| spelling | doaj.art-5f64085f029c4c7081c1ab452a6238cc2023-04-10T04:03:56ZengElsevierClinical Epidemiology and Global Health2213-39842023-03-0120101249Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunityStevent Sumantri0Maria Aurelia Haryanto1Euphemia Seto Anggraini Widyastuti2Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Corresponding author. Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Universitas Pelita Harapan Boulevard Jenderal Sudirman, Lippo Village, Karawaci, Curug, Tangerang, Banten, 15810, Indonesia.Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, IndonesiaDepartment of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, IndonesiaIntroduction: Adverse Events Following Immunization (AEFI) of the COVID-19 vaccine is one of the important considerations, especially in patients with autoimmunity. This study aims to compare the number of CoronaVac AEFIs in women with and without autoimmunity. Methodology: This is a retrospective cohort study with an unpaired comparative analytic design with a retrospective cohort method. We recruited 602 volunteers, 182 women with autoimmunity and 420 without autoimmunity. We included women who received the CoronaVac vaccine, aged 17–65 years. Data were analyzed using the chi-square or fisher exact method as an alternative. Results: We found a generally increased risk for AEFI in women with autoimmunity (RR = 1.179; 95% CI 1.059–1.313; p = 0.007) compared to women without autoimmunity, especially for systemic (RR = 1.1271; 95% CI 1.045–1.545; p = 0.025), allergic (RR = 2.052; 95% CI 1.070–3.932; p = 0.045), fever (RR = 2.163 95%; CI 1.093–4.282; p = 0.039), fatigue (RR = 2.182 95%; CI 1.558–3.056; p = 0.001), and headache (RR = 1.619 95%; CI 1.164–2.251; p = 0.006). On the other hand, we found no increased risk for the overall severity of AEFI (RR = 0.851 95% CI; 0.655–1.105; p = 0.256). We also found a relapse of autoimmune condition in 10.4% (n = 19) after CoronaVac vaccination. Conclusions: There is an increased risk of AEFI after CoronaVac vaccination in women with autoimmunity compared to those without the condition. Although the severity of AEFIs and risk of autoimmune relapse were relatively low.http://www.sciencedirect.com/science/article/pii/S2213398423000362Adverse events after immunization (AEFI)AutoimmunityCoronaVacCOVID-19 |
| spellingShingle | Stevent Sumantri Maria Aurelia Haryanto Euphemia Seto Anggraini Widyastuti Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity Clinical Epidemiology and Global Health Adverse events after immunization (AEFI) Autoimmunity CoronaVac COVID-19 |
| title | Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity |
| title_full | Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity |
| title_fullStr | Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity |
| title_full_unstemmed | Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity |
| title_short | Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity |
| title_sort | risk of adverse events following coronavac s covid 19 vaccination in women with and without autoimmunity |
| topic | Adverse events after immunization (AEFI) Autoimmunity CoronaVac COVID-19 |
| url | http://www.sciencedirect.com/science/article/pii/S2213398423000362 |
| work_keys_str_mv | AT steventsumantri riskofadverseeventsfollowingcoronavacscovid19vaccinationinwomenwithandwithoutautoimmunity AT mariaaureliaharyanto riskofadverseeventsfollowingcoronavacscovid19vaccinationinwomenwithandwithoutautoimmunity AT euphemiasetoanggrainiwidyastuti riskofadverseeventsfollowingcoronavacscovid19vaccinationinwomenwithandwithoutautoimmunity |